Publications

Jump to Selected Publications by year:

201720162015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | Prior to 2000


2018 Publications
MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection.
PLoS One. 2018 Jan 22; 12(1): e0006154.

 

View online

 Top

2017 Publications

Paquin-Proulx D, Santos BAN, Barsotti NS, Marinho AKBB, Kokron CM, Carvalho KI, Barros MT, Kalil J, Elmacken M, Sandberg JK, Kallas EG, Nixon DF.
Loss of Circulating Mucosal-Associated Invariant T Cells in Common Variable Immunodeficiency Is Associated with Immune Activation and Loss of Eomes and PLZF.
ImmunoHorizons. 2017 Sept 1; 1(7)142-155.

 

View online

de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF, Michaud HA.
Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
Retrovirology. 2017 Aug 22;14:41.

 

View online

Paquin Proulx D, Greenspun BC, Costa EAS, Segurado AC, Kallas EG, Nixon DF, Leal FE.
MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.
PLoS One. 2017 Apr 6; 12(4): e0175345.

 

View online

Raposo RA, de Mulder M, Paquin Proulx D, Brailey PM, Cabido VD, Zdinak PM, Thomas AS, Huang S, Beckerle GA, Jones RB, Nixon DF.
IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.
JCI Insight. 2017 Jan;2(1):e85811.

View online

 Top

2016 Publications

Paquin-Proulx D, Gibbs A, Bächle S, Introini A, Checa A, Leeanshyah E, Wheelock CE, Nixon DF, Broliden K, Tjernlund A, Moll M, Sandberg JK.
Innate iNKT cell sensing of HIV-1 infection in dendritic cells is an early immune detection system inhibited by Nef and Vpu.
Journal of Immunology 2016 Sep 1;197(5):1843-51.

View online

Patel S, Jones RB, Nixon DF, Bollard CM.
T-cell therapies for HIV: Preclinical successes and current clinical strategies.
Cytotherapy. 2016 Aug;18(8):931-42.

View online

Paquin-Proulx D, Barsotti NS, Santos BN, Marinho ABB, Kokron CM, Carvalho KI, Barros MT, Kalil J, Nixon DF, Kallas EG.
Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion.
Medicine (Baltimore), 2016 Jul; 95(30) :e4304.

View online

Kuebler PJ, Shaw BI, Leadabrand KS, Mehrotra ML, Grant RM, Kallás EG, Nixon DF.
Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial.
J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):184-8

View online

Paquin-Proulx D, Ching C, Vujkovic-Cvijin I, Fadrosh D, Loh L, Huang Y, Somsouk M, Lynch SV, Hunt PW, Nixon DF, SenGupta D.
Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection.
Mucosal Immunology 2016, April; DOI: 10.1038/mi.2016.34.

View online

Daubenmier J, Moran PJ, Kristeller J, Acree M, Bacchetti P, Kemeny ME, Dallman M, Lustig RH, Grunfeld C, Nixon DF, Milush JM, Goldman V, Laraia B, Laugero KD, Woodhouse L, Epel ES, Hecht FM.
Effects of a mindfulness-based weight loss intervention in adults with obesity: A randomized clinical trial.
Obesity (Silver Spring). 2016 Apr;24(4):794-804.

View online

Kuebler PJ, Mehrotra ML, Shaw BI, Leadabrand KS, Milush JM, York VA, Defechereux P, Grant RM, Kallás EG, Nixon DF.
Persistent HIV-1 Seronegative Status is Associated with Lower CD8+ T Cell Activation.
J Infect Dis. 2016 Feb 15;213(4):569-73.

View online

Top

2015 Publications

Kuebler PJ, Shaw BI, Leadabrand KS, Mehrotra ML, Grant RM, Kallás EG, Nixon DF.
HIV-1 gp120 T cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemprophylaxis Trial.
J Acquir Immune Defic Syndr. 2015 Dec 15. [Epub ahead of print]

View online

Kuebler PJ, Mehrotra ML, McConnell JJ, Holditch SJ, Shaw BI, Tarosso LF, Leadabrand KS, Milush JM, York VA, Raposo RA, Cheng RG, Eriksson EM, McMahan V, Glidden DV, Shiboski S, Grant RM, Nixon DF, Kallás EG.
Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8379-84.

View online

Almeida RR, Raposo RA, Coirada FC, da Silva JR, de Souza Ferreira LC, Kalil J, Nixon DF, Cunha-Neto E.
Modulating APOBEC expression enhances DNA vaccine immunogenicity.
Immunol Cell Biol. 2015 May 8.

View online

Eriksson EM, Liegler T, Keh CE, Karlsson AC, Holditch SJ, Pilcher CD, Loeb L, Nixon DF, Hecht FM.
Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences.
PLoS One. 2015 Apr 28;10(4):e0120787.

View online

Raposo RA, Gupta R, Abdel-Mohsen M, Dimon M, Debbaneh M, Jiang W, York VA, Leadabrand KS, Brown G, Malakouti M, Arron S, Kuebler PJ, Wu JJ, Pillai SK, Nixon DF, Liao W.
Antiviral gene expression in psoriasis. 
J Eur Acad Dermatol Venerol. 2015 Mar 23. 

View online

Top

2014 Publications

Leal FE, Michniowski M, Nixon DF.
Human T-lymphotropic virus 1, breastfeeding and anti-retroviral therapy.
AIDS Res Hum Retroviruses. 2015 Mar;31(3):271 

View online

Nixon DF, Simon GL, Raposo RA.
Test, Treat and Cure.
J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):e9-e10.

View online

Ribeiro SP, Milush JM, Cunha-Neto E, Kallas EG, Kalil J, Somsouk M, Hunt PW, Deeks SG, Nixon DF, SenGupta D.
The CD8+ memory stem T cell (TSCM) subset is associated with improved prognosis in chronic HIV-1 infection.
J Virol. 2014 Dec 1;88(23):13836-44.

View online

Gupta R, Michaud HA, Zeng X, Debbaneh M, Arron ST, Jones R, Ormsby CE, Nixon DF, Liao W.
Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis.
J Transl Med. 2014 Sep 16;12:256.

View online

Saraiva Raposo RA, Abdel-Mohsen M, Deng X, Hecht FM, Pilcher CD, Pillai SK, Nixon DF. 
Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo. 
J Virol. 2014 Oct 1;88(19):11624-9.

View online

Loh L, Ivarsson MA, Michaëlsson J, Sandberg JK, Nixon DF.
Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine. 
Mucosal Immunol. 2014 Sep;7(5):1233-43.

View online

Michaud HA, SenGupta D, de Mulder M, Deeks SG, Martin JN, Kobie JJ, Sacha JB, Nixon DF.
Cutting Edge: An Antibody Recognizing Ancestral Endogenous Virus Glycoproteins Mediates Antibody-Dependent Cellular Cytotoxicity on HIV-1-Infected Cells. 
J Immunol. 2014 Aug 15;193(4):1544-8.

View online

Gurfein BT, Davidenko O, Premenko-Lanier M, Milush JM, Acree M, Dallman MF, Touma C, Palme R, York VA, Fromentin G, Darcel N, Nixon DF, Hecht FM.
Environmental enrichment alters splenic immune cell composition and enhances secondary influenza vaccine responses in mice.
Mol Med. 2014 Apr 22;20:179-90.

View online

de Mulder M, York VA, Wiznia AA, Michaud HA, Nixon DF, Holguin A, Rosenberg MG.
HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA.
HIV Med. 2014 Mar;15(3):135-43.

View online

Sheppard NC, Jones RB, Burwitz BJ, Nimityongskul FA, Newman LP, Buechler MB, Reed JS, Piaskowski SM, Weisgrau KL, Castrovinci PA, Wilson NA, Ostrowski MA, Park B, Nixon DF, Rakasz EG, Sacha JB.
Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication.
PLoS One. 2014 Mar 20;9(3):e92012.

View online

Michaud HA, de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF.
Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
Retrovirology. 2014 Jan 28;11:10.

View online

Emu B, Moretto WJ, Hoh R, Krone M, Martin JN, Nixon DF, Deeks SG, McCune JM.
Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease. 
PLoS One. 2014 Jan21;9(1):e85613.

View online

Leeansyah E, Loh L, Nixon DF, Sandberg JK.
Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development.
Nat Commun. 2014;5:3143.

View online

Top

2013 Publications

Milush JM, López-Vergès S, York VA, Deeks SG, Martin JN, Hecht FM, Lanier LL, Nixon DF.
CD56negCD16 NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.
Retrovirology. 2013 Dec 18;10:158.

View online

Jones RB, Song H, Xu Y, Garrison KE, Buzdin AA, Anwar N, Hunter DV, Mujib S, Mihajlovic V, Martin E, Lee E, Kuciak M, Raposo RA, Bozorgzad A, Meiklejohn DA, Ndhlovu LC, Nixon DF, Ostrowski MA.
LINE-1 retrotransposable element DNA accumulates in HIV-1-infected cells. 
J Virol. 2013 Dec;87(24):13307-20.

View online

Raposo RA, Abdel-Mohsen M, Bilska M, Montefiori DC, Nixon DF, Pillai SK.
Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells.
J Virol. 2013 Nov;87(21):11924-9.

View online

Raposo RA, Abdel-Mohsen M, Holditch SJ, Kuebler PJ, Cheng RG, Eriksson EM, Liao W, Pillai SK, Nixon DF.
Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals.
J Leukoc Biol. 2013 Nov;94(5):1051-9.

View online

Abdel-Mohsen M, Raposo RA, Deng X, Li M, Liegler T, Sinclair E, Salama MS, Ghanem Hel-D, Hoh R, Wong JK, David M, Nixon DF, Deeks SG, Pillai SK.
Expression profile of host restriction factors in HIV-1 elite controllers.
Retrovirology. 2013 Oct 16;10:106.

View online

Ivarsson MA, Loh L, Marquardt N, Kekäläinen E, Berglin L, Björkström NK, Westgren M, Nixon DF, Michaëlsson J.
Differentiation and functional regulation of human fetal NK cells. 
J Clin Invest. 2013 Sep 3;123(9):3889-901.

View online

Snyder-Cappione JE, Nixon DF, Chi JC, Nguyen ML, Kirby CK, Milush JM, Koth LL.
Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis.
Eur J Immunol. 2013 Aug;43(8):2194-205.

View online

Champiat S, Garrison KE, Raposo RA, Burwitz BJ, Reed J, Tandon R, York VA, Newman LP, Nimityongskul FA, Wilson NA, Almeida RR, Martin JN, Deeks SG, Rosenberg MG, Wiznia AA, Spotts GE, Pilcher CD, Hecht FM, Ostrowski MA, Sacha JB, Nixon DF.
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.
J Virol. 2013 Jun;87(11):6073-80.

View online

Sanabani SS, Pessôa R, Soares de Oliveira AC, Martinez VP, Giret MT, de Menezes Succi RC, Carvalho K, Tomiyama CS, Nixon DF, Sabino EC, Kallas EG.
Variability of HIV-1 genomes among children and adolescents from São Paulo, Brazil. 
PLoS One. 2013 May 7;8(5):e62552.

View online

Perez CL, Milush JM, Buggert M, Eriksson EM, Larsen MV, Liegler T, Hartogensis W, Bacchetti P, Lund O, Hecht FM, Nixon DF, Karlsson AC.
Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion.
AIDS Res Hum Retroviruses. 2013 Mar;29(3):602-12.

View online

Jones RB, Leal FE, Hasenkrug AM, Segurado AC, Nixon DF, Ostrowski MA, Kallas EG.
Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods. 
J Negat Results Biomed. 2013 Jan 10;12:3.

View online

Batista MD, Ho EL, Kuebler PJ, Milush JM, Lanier LL, Kallas EG, York VA, Chang D, Liao W, Unemori P, Leslie KS, Maurer T, Nixon DF.
Skewed distribution of natural killer cells in psoriasis skin lesions.
Exp Dermatol. 2013 Jan;22(1):64-6.

View online

Leal FE, Ndhlovu LC, Hasenkrug AM, Bruno FR, Carvalho KI, Wynn-Williams H, Neto WK, Sanabani SS, Segurado AC, Nixon DF, Kallas EG.
Expansion in CD39 CD4 immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.
PLoS Negl Trop Dis. 2013;7(2):e2028.

View online

Batista MD, Tincati C, Milush JM, Ho EL, Ndhlovu LC, York VA, Kallas EG, Kalil J, Keating SM, Norris PJ, Chang D, Unemori P, Leslie KS, Maurer T, Liao W, Nixon DF.
CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasis. 
PLoS One. 2013;8(2):e52144.

View online

Top

2012 Publications

Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, Martin E, John VM, Zhan W, Faruk NF, Gyenes G, Sheppard NC, Priumboom-Brees IM, Goodwin DA, Chen L, Rieger M, Muscat-King S, Loudon PT, Stanley C, Holditch SJ, Wong JC, Clayton K, Duan E, Song H, Xu Y, SenGupta D, Tandon R, Sacha JB, Brockman MA, Benko E, Kovacs C, Nixon DF, Ostrowski MA.
HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. 
J Clin Invest. 2012 Dec3;122(12):4473-89.

View online

Sacha JB, Kim IJ, Chen L, Ullah JH, Goodwin DA, Simmons HA, Schenkman DI, von Pelchrzim F, Gifford RJ, Nimityongskul FA, Newman LP, Wildeboer S, Lappin PB, Hammond D, Castrovinci P, Piaskowski SM, Reed JS, Beheler KA, Tharmanathan T, Zhang N, Muscat-King S, Rieger M, Fernandes C, Rumpel K, Gardner JP 2nd, Gebhard DH, Janies J, Shoieb A, Pierce BG, Trajkovic D, Rakasz E, Rong S, McCluskie M, Christy C, Merson JR, Jones RB, Nixon DF, Ostrowski MA, Loudon PT, Pruimboom-Brees IM, Sheppard NC.
Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic.
J Immunol. 2012 Aug 1;189(3):1467-79.

View online

Lai OY, Chen H, Michaud HA, Hayashi G, Kuebler PJ, Hultman GK, Ariza ME, Williams MV, Batista MD, Nixon DF, Foerster J, Bowcock AM, Liao W.
Protective effect of human endogenous retrovirus K dUTPase variants on psoriasis susceptibility.
J Invest Dermatol. 2012 Jul;132(7):1833-40.

View online

Keh CE, Jha AR, Nzarubara B, Lanar DE, Dutta S, Theisen M, Rosenthal PJ, Dorsey G, Nixon DF, Greenhouse B.
Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda.
PLoS One. 2012;7(12):e52571.

View online

Sandberg JK, Andersson SK, Bächle SM, Nixon DF, Moll M.
HIV-1 Vpu interference with innate cell-mediated immune mechanisms.
Curr HIV Res. 2012 Jun;10(4):327-33. Review.

View online

Gurfein BT, Stamm AW, Bacchetti P, Dallman MF, Nadkarni NA, Milush JM, Touma C, Palme R, Di Borgo CP, Fromentin G, Lown-Hecht R, Konsman JP, Acree M, Premenko-Lanier M, Darcel N, Hecht FM, Nixon DF.
The calm mouse: an animal model of stress reduction.
Mol Med. 2012 May 9;18:606-17.

View online

Carvalho KI, Bruno FR, Snyder-Cappione JE, Maeda SM, Tomimori J, Xavier MB, Haslett PA, Nixon DF, Kallas EG.
Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.
Immunology. 2012 May;136(1):96-102.

View online

Ndhlovu LC, Lopez-Vergès S, Barbour JD, Jones RB, Jha AR, Long BR, Schoeffler EC, Fujita T, Nixon DF, Lanier LL.
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. 
Blood. 2012 Apr19;119(16):3734-43.

View online

Jones RB, John VM, Hunter DV, Martin E, Mujib S, Mihajlovic V, Burgers PC, Luider TM, Gyenes G, Sheppard NC, Sengupta D, Tandon R, Yue FY, Benko E, Kovacs C, Nixon DF, Ostrowski MA.
Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.
Clin Vaccine Immunol. 2012 Feb;19(2):288-92.

View online

Chen H, Hayashi G, Lai OY, Dilthey A, Kuebler PJ, Wong TV, Martin MP, Fernandez Vina MA, McVean G, Wabl M, Leslie KS, Maurer T, Martin JN, Deeks SG, Carrington M, Bowcock AM, Nixon DF, Liao W.
Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease.
PLoS Genet. 2012 Feb;8(2):e1002514.

View online

Eriksson EM, Milush JM, Ho EL, Batista MD, Holditch SJ, Keh CE, Norris PJ, Keating SM, Deeks SG, Hunt PW, Martin JN, Rosenberg MG, Hecht FM, Nixon DF.
Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.
Blood. 2012 Jan19;119(3):745-55.

View online

de Vos G, Milush JM, Aaron J, Pichardo Y, York VA, Nazari R, Rosenstreich D, Nixon DF, Wiznia A.
Peripheral CD8+ T-cell levels are decreased in atopic wheezing children aged less than 4 years.
J Investig Allergol Clin Immunol. 2012;22(6):442-4.

View online

Keh CE, Jha AR, Nzarubara B, Lanar DE, Dutta S, Theisen M, Rosenthal PJ, Dorsey G, Nixon DF, Greenhouse B.
Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda.
PLoS One. 2012;7(12):e52571.

View online

Eriksson EM, Keh CE, Deeks SG, Martin JN, Hecht FM, Nixon DF.
Differential expression of CD96 surface molecule represents CD8 T cells with dissimilar effector function during HIV-1 infection.
PLoS One. 2012;7(12):e51696.

View online

Tandon R, Giret MT, Sengupta D, York VA, Wiznia AA, Rosenberg MG, Kallas EG, Ndhlovu LC, Nixon DF.
Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children. 
PLoS One. 2012;7(9):e45733.

View online

Ormsby CE, Sengupta D, Tandon R, Deeks SG, Martin JN, Jones RB, Ostrowski MA, Garrison KE, Vázquez-Pérez JA, Reyes-Terán G, Nixon DF.
Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.
PLoS One. 2012;7(8):e41021.

View online

Champiat S, Raposo RA, Maness NJ, Lehman JL, Purtell SE, Hasenkrug AM, Miller JC, Dean H, Koff WC, Hong MA, Martin JN, Deeks SG, Spotts GE, Pilcher CD, Hecht FM, Kallas EG, Garrison KE, Nixon DF.
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection.
PLoS One.2012;7(6):e39311.

View online

Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF.
Association of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected children.
PLoS One. 2012;7(1):e29154.

View online

Top

2011 Publications

Tandon R, SenGupta D, Ndhlovu LC, Vieira RG, Jones RB, York VA, Vieira VA, Sharp ER, Wiznia AA, Ostrowski MA, Rosenberg MG, Nixon DF.
Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects. 
J Virol. 2011 Nov;85(21):11526-31.

View online

Lopez-Vergès S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, Houchins JP, Miller S, Kang SM, Norris PJ, Nixon DF, Lanier LL.
Expansion of a unique CD57NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32.

View online

SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, York VA, Spotts G, Reyes-Terán G, Ostrowski MA, Hecht FM, Deeks SG, Nixon DF.
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. 
J Virol. 2011 Jul;85(14):6977-85.

View online

Ndhlovu LC, Leal FE, Hasenkrug AM, Jha AR, Carvalho KI, Eccles-James IG, Bruno FR, Vieira RG, York VA, Chew GM, Jones RB, Tanaka Y, Neto WK, Sanabani SS, Ostrowski MA, Segurado AC, Nixon DF, Kallas EG.
HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications.
PLoS Negl Trop Dis. 2011 Apr 26;5(4):e1030.

View online

Kuylenstierna C, Snyder-Cappione JE, Loo CP, Long BR, Gonzalez VD, Michaëlsson J, Moll M, Spotts G, Hecht FM, Nixon DF, Sandberg JK.
NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infection.
Scand J Immunol. 2011 Feb;73(2):141-6.

View online

Holditch SJ, Eriksson EM, Tarosso LF, Kuebler PJ, Kallas EG, Nielsen EK, Wiznia AA, Rosenberg MG, Nixon DF.
Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants. 
Front Immunol. 2012 Jan 11;2:94.

View online

Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF.
Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.
PLoS One. 2011;6(7):e21135.

View online

Jha AR, Nixon DF, Rosenberg MG, Martin JN, Deeks SG, Hudson RR, Garrison KE, Pillai SK.
Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans.
PLoS One. 2011;6(5):e20234.

View online

Top

2010 Publications

Lopez-Vergès S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, Norris PJ, Nixon DF, Lanier LL.
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. 
Blood. 2010 Nov11;116(19):3865-74.

View online

Snyder-Cappione JE, Tincati C, Eccles-James IG, Cappione AJ, Ndhlovu LC, Koth LL, Nixon DF.
A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males.
PLoS One. 2010 Nov 3;5(11):e15412.

View online

Streeck H, Nixon DF.
T cell immunity in acute HIV-1 infection. 
J Infect Dis. 2010 Oct 15;202 Suppl 2:S302-8. Review.

View online

Carvalho KI, Melo KM, Bruno FR, Snyder-Cappione JE, Nixon DF, Costa-Carvalho BT, Kallas EG.
Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID).
PLoS One. 2010 Sep 9;5(9). pii: e12652.

View online

Ndhlovu LC, Sinclair E, Epling L, Tan QX, Ho T, Jha AR, Eccles-James I, Tincati C, Levy JA, Nixon DF, Hecht FM, Barbour JD.
IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. 
J Clin Immunol. 2010 Sep;30(5):681-92.

View online

Willberg CB, Garrison KE, Jones RB, Meiklejohn DJ, Spotts G, Liegler TJ, Ostrowski MA, Karlsson AC, Hecht FM, Nixon DF.
Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
PLoS One. 2010 Apr 21;5(4):e10249.

View online

Long BR, Erickson AE, Chapman JM, Barbour JD, Vu BA, Ho EL, Lanier LL, Sauer MM, Carvalho KI, Nixon DF, Kallas EG.
Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2. 
Immunology. 2010 Feb;129(2):186-96.

View online

Ndhlovu LC, Leal FE, Eccles-James IG, Jha AR, Lanteri M, Norris PJ, Barbour JD, Wachter DJ, Andersson J, Taskén K, Torheim EA, Aandahl EM, Kallas EG, Nixon DF.
A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties.
Eur J Immunol. 2010 Jan;40(1):134-41.

View online

Schweighardt B, Wrin T, Meiklejohn DA, Spotts G, Petropoulos CJ, Nixon DF, Hecht FM.
Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption.
J Acquir Immune Defic Syndr. 2010 Jan;53(1):36-46.

View online

Top

2009 Publications

Ndhlovu LC, Snyder-Cappione JE, Carvalho KI, Leal FE, Loo CP, Bruno FR, Jha AR, Devita D, Hasenkrug AM, Barbosa HM, Segurado AC, Nixon DF, Murphy EL, Kallas EG.
Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.
Clin Exp Immunol. 2009 Dec;158(3):294-9.

View online

Milush JM, Long BR, Snyder-Cappione JE, Cappione AJ 3rd, York VA, Ndhlovu LC, Lanier LL, Michaëlsson J, Nixon DF.
Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.
Blood. 2009 Nov 26;114(23):4823-31.

View online

Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ.
Tregs control the development of symptomatic West Nile virus infection in humans and mice. 
J Clin Invest. 2009 Nov;119(11):3266-77.

View online

Jha AR, Pillai SK, York VA, Sharp ER, Storm EC, Wachter DJ, Martin JN, Deeks SG, Rosenberg MG, Nixon DF, Garrison KE.
Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens.
Mol Biol Evol. 2009 Nov;26(11):2617-26.

View online

Snyder-Cappione JE, Loo CP, Carvalho KI, Kuylenstierna C, Deeks SG, Hecht FM, Rosenberg MG, Sandberg JK, Kallas EG, Nixon DF.
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression. 
AIDS. 2009 Sep 24;23(15):1965-70.

View online

Garrison KE, Champiat S, York VA, Agrawal AT, Kallas EG, Martin JN, Hecht FM, Deeks SG, Nixon DF.
Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses.
Clin Vaccine Immunol. 2009 Sep;16(9):1369-71.

View online

Melo KM, Carvalho KI, Bruno FR, Ndhlovu LC, Ballan WM, Nixon DF, Kallas EG, Costa-Carvalho BT.
A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.
PLoS One. 2009 Jul 29;4(7):e6269.

View online

Loo CP, Long BR, Hecht FM, Nixon DF, Michaëlsson J.
HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.
AIDS Res Hum Retroviruses. 2009 Jun;25(6):603-5.

View online

Torheim EA, Ndhlovu LC, Pettersen FO, Larsen TL, Jha AR, Torgersen KM, Kvale D, Nixon DF, Taskén K, Aandahl EM.
Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population.
Eur J Immunol. 2009 May;39(5):1280-7.

View online

Cheng RG, Nixon DF.
Herpes simplex virus and HIV-1: deciphering viral synergy. 
Lancet Infect Dis. 2009 Feb;9(2):74; author reply 74-5.

View online

Top

2008 Publications

Mold JE, Michaëlsson J, Burt TD, Muench MO, Beckerman KP, Busch MP, Lee TH, Nixon DF, McCune JM.
Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. 
Science. 2008 Dec 5;322(5907):1562-5.

View online

Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman JM, Gyenes G, Vali B, Hyrcza MD, Yue FY, Kovacs C, Sassi A, Loutfy M, Halpenny R, Persad D, Spotts G, Hecht FM, Chun TW, McCune JM, Kaul R, Rini JM, Nixon DF, Ostrowski MA.
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. 
J Exp Med. 2008 Nov 24;205(12):2763-79.

View online

Erickson AL, Willberg CB, McMahan V, Liu A, Buchbinder SP, Grohskopf LA, Grant RM, Nixon DF.
Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level.
Clin Vaccine Immunol. 2008 Nov;15(11):1745-8.

View online

Willberg CB, McConnell JJ, Eriksson EM, Bragg LA, York VA, Liegler TJ, Hecht FM, Grant RM, Nixon DF.
Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus. 
PLoS Pathog. 2008 Oct;4(10):e1000185.

View online

Michaëlsson J, Barbosa HM, Jordan KA, Chapman JM, Brunialti MK, Neto WK, Nukui Y, Sabino EC, Chieia MA, Oliveira AS, Nixon DF, Kallas EG.
The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis.
BMC Immunol. 2008 Jul 29;9:41.

View online

Ndhlovu LC, Chapman JM, Jha AR, Snyder-Cappione JE, Pagán M, Leal FE, Boland BS, Norris PJ, Rosenberg MG, Nixon DF.
Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection.
AIDS. 2008 May 11;22(8):990-2.

View online

McLaughlin BE, Baumgarth N, Bigos M, Roederer M, De Rosa SC, Altman JD, Nixon DF, Ottinger J, Oxford C, Evans TG, Asmuth DM.
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach.
Cytometry A. 2008 May;73(5):400-10.

View online

McLaughlin BE, Baumgarth N, Bigos M, Roederer M, De Rosa SC, Altman JD, Nixon DF, Ottinger J, Li J, Beckett L, Shacklett BL, Evans TG, Asmuth DM.
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms.
Cytometry A. 2008 May;73(5):411-20.

View online

Long BR, Ndhlovu LC, Oksenberg JR, Lanier LL, Hecht FM, Nixon DF, Barbour JD.
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.
J Virol. 2008 May;82(10):4785-92.

View online

Pérez CL, Larsen MV, Gustafsson R, Norström MM, Atlas A, Nixon DF, Nielsen M, Lund O, Karlsson AC.
Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes.
J Immunol. 2008 Apr 1;180(7):5092-100.

View online

Lee AW, Sharp ER, O'Mahony A, Rosenberg MG, Israelski DM, Nolan GP, Nixon DF.
Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection.
J Virol. 2008 Apr;82(7):3702-12.

View online

Jones RB, Garrison KE, Wong JC, Duan EH, Nixon DF, Ostrowski MA.
Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition.
PLoS One. 2008 Feb 6;3(2):e1547.

View online

Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM.
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
J Leukoc Biol. 2008 Feb;83(2):254-62.

View online

Long BR, Michaelsson J, Loo CP, Ballan WM, Vu BA, Hecht FM, Lanier LL, Chapman JM, Nixon DF.
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus. 
Clin Vaccine Immunol. 2008 Jan;15(1):120-30.

View online

Michaëlsson J, Long BR, Loo CP, Lanier LL, Spotts G, Hecht FM, Nixon DF.
Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.
J Infect Dis. 2008 Jan 1;197(1):117-25.

View online

Top

2007 Publications

Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, Erickson AL, Agrawal A, Spotts G, Hecht FM, Rakoff-Nahoum S, Lenz J, Ostrowski MA, Nixon DF.
T cell responses to human endogenous retroviruses in HIV-1 infection.
PLoS Pathog. 2007 Nov;3(11):e165.

Barbour JD, Sauer MM, Sharp ER, Garrison KE, Long BR, Tomiyama H, Bassichetto KC, Oliveira SM, Abbate MC, Nixon DF, Kallas EG.
HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts.
PLoS One. 2007 Oct24;2(10):e1080.

Karlsson AC, Chapman JM, Heiken BD, Hoh R, Kallas EG, Martin JN, Hecht FM, Deeks SG, Nixon DF.
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to Pol.
J Virol. 2007 Oct;81(20):11543-8.

Ballan WM, Vu BA, Long BR, Loo CP, Michaëlsson J, Barbour JD, Lanier LL, Wiznia AA, Abadi J, Fennelly GJ, Rosenberg MG, Nixon DF.
Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.
J Immunol. 2007 Sep 1;179(5):3362-70.

Willberg CB, Pillai SK, Sharp ER, Rosenberg MG, Agudelo JD, Barbour JD, Nixon DF.
Rational peptide selection to detect human immunodeficiency virus type1-specific T-cell responses under resource-limited conditions.
Clin Vaccine Immunol. 2007 Jun;14(6):785-8.

Northfield JW, Loo CP, Barbour JD, Spotts G, Hecht FM, Klenerman P, Nixon DF, Michaëlsson J.
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.
J Virol. 2007 Jun;81(11):5759-65. Epub 2007 Mar 21.

Snyder-Cappione JE, Nixon DF, Loo CP, Chapman JM, Meiklejohn DA, Melo FF, Costa PR, Sandberg JK, Rodrigues DS, Kallas EG.
Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells.
J Infect Dis. 2007 May 1;195(9):1361-4.

Karlsson AC, Iversen AK, Chapman JM, de Oliviera T, Spotts G, McMichael AJ, Davenport MP, Hecht FM, Nixon DF.
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
PLoS One. 2007 Feb 21;2(2):e225.

Carr WH, Rosen DB, Arase H, Nixon DF, Michaelsson J, Lanier LL.
Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation.
J Immunol. 2007 Jan 15;178(2):647-51.

Willberg CB, Nixon DF.
Treatment interruption in chronic HIV-1 infection: does it deliver?
Curr Opin HIV AIDS. 2007 Jan;2(1):26-30.

View online

Top

2006 Publications

Metzner KJ, Binley JM, Gettie A, Marx P, Nixon DF, Connor RI.
Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.
Retrovirology. 2006 Dec 21;3:97.

Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, Diaz RS, Santos AM, Succi RC, Abadi J, Rosenberg MG, de Moraes-Pinto MI, Kallas EG.
Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.
PLoS One. 2006 Dec 20;1:e102.

Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, Hunter E, Klein G, Korber B, Kuritzkes DR, Lederman MM, Malim MH, Marx PA, McCune JM, McMichael A, Miller C, Miller V, Montagnier L, Montefiori DC, Moore JP, Nixon DF, Overbaugh J, Pauza CD, Richman DD, Saag MS, Sattentau Q, Schooley RT, Shattock R, Shaw GM, Stevenson M, Trkola A, Wainberg MA, Weiss RA, Wolinsky S, Zack JA.
A plea for justice for jailed medical workers.
Science. 2006 Nov 10;314(5801):924-5.

Nomura LE, Emu B, Hoh R, Haaland P, Deeks SG, Martin JN, McCune JM, Nixon DF, Maecker HT.
IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells.
AIDS Res Ther. 2006 Jul 21;3:18.

Michaëlsson J, Mold JE, McCune JM, Nixon DF.
Regulation of T cell responses in the developing human fetus.
J Immunol. 2006 May 15;176(10):5741-8.

Moll M, Snyder-Cappione J, Spotts G, Hecht FM, Sandberg JK, Nixon DF.
Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2.
Blood. 2006 Apr 15;107(8):3081-3.

Jordan KA, Furlan SN, Gonzalez VD, Karlsson AC, Quigley MF, Deeks SG, Rosenberg MG, Nixon DF, Sandberg JK.
CD8 T cell effector maturation in HIV-1-infected children.
Virology. 2006 Mar 30;347(1):117-26.

Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM.
Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.
Clin Infect Dis. 2006 Mar 1;42(5):700-8.

Rakoff-Nahoum S, Kuebler PJ, Heymann JJ, E Sheehy M, Ortiz GM, S Ogg G, Barbour JD, Lenz J, Steinfeld AD, Nixon DF.
Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. 
AIDS Res Hum Retroviruses. 2006 Jan;22(1):52-6.

Papasavvas E, Kostman JR, Thiel B, Pistilli M, Mackiewicz A, Foulkes A, Gross R, Jordan KA, Nixon DF, Grant R, Poulin JF, McCune JM, Mounzer K, Montaner LJ.
HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption.
J Clin Immunol. 2006 Jan;26(1):40-54.

Top

2005 Publications

Metzner KJ, Moretto WJ, Donahoe SM, Jin X, Gettie A, Montefiori DC, Marx PA,  Binley JM, Nixon DF, Connor RI.
Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.
J Gen Virol. 2005 Dec;86(Pt12):3375-84.

Sharp ER, Barbour JD, Karlsson RK, Jordan KA, Sandberg JK, Wiznia A, Rosenberg MG, Nixon DF.
Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1.
J Infect Dis. 2005 Nov 15;192(10):1772-80.

Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, Martin JN, Nixon DF, McCune JM, Deeks SG.
Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.
J Virol. 2005 Nov;79(22):14169-78.

Legrand FA, Abadi J, Jordan KA, Davenport MP, Deeks SG, Fennelly GJ, Wiznia AA, Nixon DF, Rosenberg MG.
Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients.
AIDS. 2005 Oct 14;19(15):1575-85.

Nixon DF, Deeks SG, Shacklett BL, Karlsson AC.
Multidrug-resistant, dual-tropic HIV-1 and rapid progression.
Lancet. 2005 Jun 4-10;365(9475):1924-5.

Nixon DF, Aandahl EM, Michaëlsson J.
CD4+CD25+ regulatory T cells in HIV infection.
Microbes Infect. 2005 Jun;7(7-8):1063-5. Review.

Top

2004 Publications

Aandahl EM, Quigley MF, Moretto WJ, Moll M, Gonzalez VD, Sönnerborg A, Lindbäck S, Hecht FM, Deeks SG, Rosenberg MG, Nixon DF, Sandberg JK.
Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment.
Blood. 2004 Dec 1;104(12):3672-8.

Schweighardt B, Roy AM, Meiklejohn DA, Grace EJ 2nd, Moretto WJ, Heymann JJ, Nixon DF.
R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.
J Virol. 2004 Sep;78(17):9164-73.

Plana M, Garcia F, Oxenius A, Ortiz GM, Lopez A, Cruceta A, Mestre G, Fumero E, Fagard C, Sambeat MA, Segura F, Miró JM, Arnedo M, Lopalcos L, Pumarola T, Hirschel B, Phillips RE, Nixon DF, Gallart T, Gatell JM.
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):791-9.

Shacklett BL, Cox CA, Quigley MF, Kreis C, Stollman NH, Jacobson MA, Andersson J, Sandberg JK, Nixon DF.
Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection.
J Immunol. 2004 Jul 1;173(1):641-8.

Shacklett BL, Cox CA, Wilkens DT, Karl Karlsson R, Nilsson A, Nixon DF, Price RW.
Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection.
J Infect Dis. 2004 Jun 15;189(12):2202-12.

Sandberg JK, Stoddart CA, Brilot F, Jordan KA, Nixon DF.
Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7.
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7058-63.

Meiklejohn DA, Karlsson RK, Karlsson AC, Chapman JM, Nixon DF, Schweighardt B.
ELISPOT cell rescue.
J Immunol Methods. 2004 May;288(1-2):135-47.

Karlsson AC, Younger SR, Martin JN, Grossman Z, Sinclair E, Hunt PW, Hagos E, Nixon DF, Deeks SG.
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.
AIDS. 2004 Apr 30;18(7):981-9.

Ramsburg E, Rose NF, Marx PA, Mefford M, Nixon DF, Moretto WJ, Montefiori D, Earl P, Moss B, Rose JK.
Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol.
J Virol. 2004 Apr;78(8):3930-40.

Aandahl EM, Michaëlsson J, Moretto WJ, Hecht FM, Nixon DF.
Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.
J Virol. 2004 Mar;78(5):2454-9.

Karlsson RK, Jennes W, Page-Shafer K, Nixon DF, Shacklett BL.
Poorly soluble peptides can mimic authentic ELISPOT responses. 
J Immunol Methods. 2004 Feb1;285(1):89-92.

Chandwani R, Jordan KA, Shacklett BL, Papasavvas E, Montaner LJ, Rosenberg MG, Nixon DF, Sandberg JK.
Limited magnitude and breadth in the HLA-A2-restricted CD8 T-Cell response to Nef in children with vertically acquired HIV-1 infection.
Scand J Immunol. 2004 Jan;59(1):109-14.

Top

2003 Publications

Alexander TH, Ortiz GM, Wellons MF, Allen A, Grace EJ 2nd, Schweighardt B, Brancato J, Sandberg JK, Furlan SN, Miralles GD, Nixon DF, Bartlett JA.
Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection.
J Acquir Immune Defic Syndr. 2003 Dec15;34(5):475-81.

Karlsson AC, Martin JN, Younger SR, Bredt BM, Epling L, Ronquillo R, Varma A, Deeks SG, McCune JM, Nixon DF, Sinclair E.
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells.
J Immunol Methods. 2003 Dec;283(1-2):141-53.

Papasavvas E, Sandberg JK, Rutstein R, Moore EC, Mackiewicz A, Thiel B, Pistilli M, June RR, Jordan KA, Gross R, Maino VC, Nixon DF, Montaner LJ.
Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
J Infect Dis. 2003 Sep 15;188(6):873-82. Erratum in: J Infect Dis. 2003 Dec15;188(12):1961.

Shacklett BL, Yang O, Hausner MA, Elliott J, Hultin L, Price C, Fuerst M, Matud J, Hultin P, Cox C, Ibarrondo J, Wong JT, Nixon DF, Anton PA, Jamieson BD.  
Optimization of methods to assess human mucosal T-cell responses to HIV infection.
J Immunol Methods. 2003 Aug;279(1-2):17-31

Karlsson AC, Deeks SG, Barbour JD, Heiken BD, Younger SR, Hoh R, Lane M, Sällberg M, Ortiz GM, Demarest JF, Liegler T, Grant RM, Martin JN, Nixon DF.
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene.
J Virol. 2003 Jun;77(12):6743-52.

Shacklett BL, Cox CA, Sandberg JK, Stollman NH, Jacobson MA, Nixon DF.
Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.
J Virol. 2003 May;77(10):5621-31.

Sandberg JK, Fast NM, Jordan KA, Furlan SN, Barbour JD, Fennelly G, Dobroszycki J, Spiegel HM, Wiznia A, Rosenberg MG, Nixon DF.  
HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment.
J Immunol. 2003 Apr 15;170(8):4403-10.

Sandberg JK, Bhardwaj N, Nixon DF.
Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment.
Eur J Immunol. 2003 Mar;33(3):588-96.

Aandahl EM, Sandberg JK, Beckerman KP, Taskén K, Moretto WJ, Nixon DF.
CD7 is a differentiation marker that identifies multiple CD8 T cell effector subsets.
J Immunol. 2003 Mar 1;170(5):2349-55.

Nixon DF, Aandahl EM, Sandberg JK.
New observations on CD8 cell responses.
AIDS. 2003;17 Suppl 4:S61-5. Review.

Top

2002 Publications

Jennes W, Kestens L, Nixon DF, Shacklett BL. 
Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15--the Amplispot assay.
J Immunol Methods. 2002 Dec1;270(1):99-108.

Schweighardt B, Ortiz GM, Grant RM, Wellons M, Miralles GD, Kostrikis LG, Bartlett JA, Nixon DF.
Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.
AIDS. 2002 Nov 22;16(17):2342-4.

Shacklett BL, Ling B, Veazey RS, Luckay A, Moretto WJ, Wilkens DT, Hu J, Israel ZR, Nixon DF, Marx PA.
Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251.
AIDS Res Hum Retroviruses. 2002 Sep 20;18(14):1081-8.

Keir ME, Rosenberg MG, Sandberg JK, Jordan KA, Wiznia A, Nixon DF, Stoddart CA, McCune JM.
Generation of CD3+CD8low thymocytes in the HIV type 1-infected thymus.
J Immunol. 2002 Sep 1;169(5):2788-96.

Sandberg JK, Fast NM, Palacios EH, Fennelly G, Dobroszycki J, Palumbo P, Wiznia A, Grant RM, Bhardwaj N, Rosenberg MG, Nixon DF.
Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.
J Virol. 2002 Aug;76(15):7528-34.

Shacklett BL, Means RE, Larsson M, Wilkens DT, Beadle TJ, Merritt MJ, Bhardwaj N, Palumbo PE, Skurnick JH, Louria DB, Nixon DF.
Dendritic cell amplification of HIV type 1-specific CD8+ T cell responses in exposed, seronegative heterosexual women.
AIDS Res Hum Retroviruses. 2002 Jul20;18(11):805-15.

Aandahl EM, Moretto WJ, Haslett PA, Vang T, Bryn T, Tasken K, Nixon DF.
Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I.
J Immunol. 2002 Jul 15;169(2):802-8.

Klenerman P, Tolfvenstam T, Price DA, Nixon DF, Broliden K, Oxenius A.
T lymphocyte responses against human parvovirus B19: small virus, big response.
Pathol Biol (Paris). 2002 Jun;50(5):317-25. Review.

Skurnick JH, Palumbo P, DeVico A, Shacklett BL, Valentine FT, Merges M, Kamin-Lewis R, Mestecky J, Denny T, Lewis GK, Lloyd J, Praschunus R, Baker A, Nixon DF, Stranford S, Gallo R, Vermund SH, Louria DB.
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.
J Infect Dis. 2002 Feb 15;185(4):428-38.

Larsson M, Wilkens DT, Fonteneau JF, Beadle TJ, Merritt MJ, Kost RG, Haslett PA, Cu-Uvin S, Bhardwaj N, Nixon DF, Shacklett BL.
Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells.  
AIDS. 2002 Jan25;16(2):171-80.

Ortiz GM, Hu J, Goldwitz JA, Chandwani R, Larsson M, Bhardwaj N, Bonhoeffer S, Ramratnam B, Zhang L, Markowitz MM, Nixon DF.
Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection.
J Virol. 2002 Jan;76(1):411-5.

Top

2001 Publications

Ortiz GM, Wellons M, Brancato J, Vo HT, Zinn RL, Clarkson DE, Van Loon K, Bonhoeffer S, Miralles GD, Montefiori D, Bartlett JA, Nixon DF.
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13288-93.

Hioe CE, Tuen M, Chien PC Jr, Jones G, Ratto-Kim S, Norris PJ, Moretto WJ, Nixon DF, Gorny MK, Zolla-Pazner S.
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120.
J Virol. 2001 Nov;75(22):10950-7.

Rose NF, Marx PA, Luckay A, Nixon DF, Moretto WJ, Donahoe SM, Montefiori D, Roberts A, Buonocore L, Rose JK.
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.
Cell. 2001 Sep7;106(5):539-49.

Sandberg JK, Fast NM, Nixon DF.
Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes.
J Immunol. 2001 Jul1;167(1):181-7.

García F, Plana M, Ortiz GM, Bonhoeffer S, Soriano A, Vidal C, Cruceta A, Arnedo M, Gil C, Pantaleo G, Pumarola T, Gallart T, Nixon DF, Miró JM, Gatell JM.
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection.
AIDS. 2001 Jun 15;15(9):F29-40.

McDermott AB, Spiegel HM, Irsch J, Ogg GS, Nixon DF.
A simple and rapid magnetic bead separation technique for the isolation of tetramer-positive virus-specific CD8 T cells.
AIDS. 2001 Apr 13;15(6):810-2.

Sheehy ME, McDermott AB, Furlan SN, Klenerman P, Nixon DF.
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis.
J Immunol Methods. 2001 Mar 1;249(1-2):99-110. Erratum in: J Immunol Methods 2001 Jun1;252(1-2):219-20.

Komanduri KV, Donahoe SM, Moretto WJ, Schmidt DK, Gillespie G, Ogg GS, Roederer M, Nixon DF, McCune JM.
Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
Virology. 2001 Jan 20;279(2):459-70.

Tolfvenstam T, Oxenius A, Price DA, Shacklett BL, Spiegel HM, Hedman K, Norbeck O, Levi M, Olsen K, Kantzanou M, Nixon DF, Broliden K, Klenerman P.
Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.
J Virol. 2001 Jan;75(1):540-3.

Top

2000 Publications

Moretto WJ, Drohan LA, Nixon DF.
Rapid quantification of SIV-specific CD8 T cell responses with recombinant vaccinia virus ELISPOT or cytokine flow cytometry.
AIDS. 2000 Nov 10;14(16):2625-7.

Bonhoeffer S, Rembiszewski M, Ortiz GM, Nixon DF.
Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection.
AIDS. 2000 Oct 20;14(15):2313-22.

Shacklett BL, Cu-Uvin S, Beadle TJ, Pace CA, Fast NM, Donahue SM, Caliendo AM, Flanigan TP, Carpenter CC, Nixon DF.
Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface.
AIDS. 2000 Sep 8;14(13):1911-5.

Papasavvas E, Ortiz GM, Gross R, Sun J, Moore EC, Heymann JJ, Moonis M, Sandberg JK, Drohan LA, Gallagher B, Shull J, Nixon DF, Kostman JR, Montaner LJ.
Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption.
J Infect Dis. 2000 Sep;182(3):766-75.

Lechner F, Sullivan J, Spiegel H, Nixon DF, Ferrari B, Davis A, Borkowsky B, Pollack H, Barnes E, Dusheiko G, Klenerman P.
Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers.
Philos Trans R Soc Lond B Biol Sci. 2000 Aug 29;355(1400):1085-92.

Shacklett BL, Beadle TJ, Pacheco PA, Grendell JH, Haslett PA, King AS, Ogg GS, Basuk PM, Nixon DF.
Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut-associated lymphoid tissue (GALT) of HIV type 1-infected subjects.
AIDS Res Hum Retroviruses. 2000 Aug 10;16(12):1157-62.

Larsson M, Messmer D, Somersan S, Fonteneau JF, Donahoe SM, Lee M, Dunbar PR, Cerundolo V, Julkunen I, Nixon DF, Bhardwaj N.
Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.
J Immunol. 2000 Aug 1;165(3):1182-90.

Donahoe SM, Moretto WJ, Samuel RV, Metzner KJ, Marx PA, Hanke T, Connor RI, Nixon DF.
Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.
Virology. 2000 Jul 5;272(2):347-56.

Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL.
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.
J Exp Med. 2000 Jul 3;192(1):63-75.

Spiegel HM, Chandwani R, Sheehy ME, Dobroszycki J, Fennelly G, Wiznia A, Radding J, Rigaud M, Pollack H, Borkowsky W, Rosenberg M, Nixon DF.
The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children.
J Infect Dis. 2000 Jul;182(1):88-95.

Shacklett BL, Beadle TJ, Pacheco PA, Grendell JH, Haslett PA, King AS, Ogg GS, Basuk PM, Nixon DF.
Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects.
Virology. 2000 May10;270(2):317-27.  

Binley JM, Schiller DS, Ortiz GM, Hurley A, Nixon DF, Markowitz MM, Moore JP.
The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy.
J Infect Dis. 2000 Apr;181(4):1249-63.

Haslett PA, Nixon DF, Shen Z, Larsson M, Cox WI, Manandhar R, Donahoe SM, Kaplan G.
Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.
J Infect Dis. 2000 Apr;181(4):1264-72.

Seth A, Yasutomi Y, Jacoby H, Callery JC, Kaminsky SM, Koff WC, Nixon DF, Letvin NL.
Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals.
AIDS Res Hum Retroviruses. 2000 Mar 1;16(4):337-43.

Nixon DF, Donahoe SM, Kakimoto WM, Samuel RV, Metzner KJ, Gettie A, Hanke T, Marx PA, Connor RI.
Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
Virology. 2000 Jan5;266(1):203-10.

Jin X, Roberts CG, Nixon DF, Safrit JT, Zhang LQ, Huang YX, Bhardwaj N, Jesdale B, DeGroot AS, Koup RA.
Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm.
AIDS Res Hum Retroviruses. 2000 Jan 1;16(1):67-76.

Jin X, Demoitie MA, Donahoe SM, Ogg GS, Bonhoeffer S, Kakimoto WM, Gillespie G, Moss PA, Dyer W, Kurilla MG, Riddell SR, Downie J, Sullivan JS, McMichael AJ, Workman C, Nixon DF.
High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections.
J Infect Dis. 2000 Jan;181(1):165-75.

Spiegel HM, Ogg GS, DeFalcon E, Sheehy ME, Monard S, Haslett PA, Gillespie G, Donahoe SM, Pollack H, Borkowsky W, McMichael AJ, Nixon DF.
Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells.
J Virol. 2000 Jan;74(2):1018-22.

Top

Prior-to-2000 Publications

Ortiz GM, Nixon DF, Trkola A, Binley J, Jin X, Bonhoeffer S, Kuebler PJ, Donahoe SM, Demoitie MA, Kakimoto WM, Ketas T, Clas B, Heymann JJ, Zhang L, Cao Y, Hurley A, Moore JP, Ho DD, Markowitz M.
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.
J Clin Invest. 1999 Sep;104(6):R13-8.

Spiegel HM, DeFalcon E, Ogg GS, Larsson M, Beadle TJ, Tao P, McMichael AJ, Bhardwaj N, O'Callaghan C, Cox WI, Krasinski K, Pollack H, Borkowsky W, Nixon DF.
Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children.
J Infect Dis. 1999 Aug;180(2):359-68.

Dhodapkar MV, Steinman RM, Sapp M, Desai H, Fossella C, Krasovsky J, Donahoe SM, Dunbar PR, Cerundolo V, Nixon DF, Bhardwaj N.
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.
J Clin Invest. 1999 Jul;104(2):173-80.

Nixon DF, Douek D, Kuebler PJ, Jin X, Vesanen M, Bonhoeffer S, Cao Y, Koup RA, Ho DD, Markowitz M.
Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy.
Immunol Lett. 1999 Mar;66(1-3):219-28.

Kakimoto WM, Gettie A, Smith S, Donahoe SM, Jin X, Marx P, Connor R, Nixon DF.
Comparison of restimulation methods to elicit SIV specific cytotoxic T-lymphocytes (CTL) in vitro: Staphylococcal enterotoxin B (SEB) provides a novel method for the quantification of SIV specific CTL precursors.
Immunol Lett. 1999 Mar;66(1-3):135-40.

Markowitz M, Vesanen M, Tenner-Racz K, Cao Y, Binley JM, Talal A, Hurley A,  Jin X, Chaudhry MR, Yaman M, Frankel S, Heath-Chiozzi M, Leonard JM, Moore JP, Racz P, Nixon DF, Ho DD.
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.
J Infect Dis. 1999 Mar;179(3):527-37. Erratum in: J Infect Dis 1999 May;179(5):1315. J X [corrected to Jin X].

Ogg GS, Jin X, Bonhoeffer S, Moss P, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Hurley A, Markowitz M, Ho DD, McMichael AJ, Nixon DF.
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.
J Virol. 1999 Jan;73(1):797-800.

Dyer WB, Ogg GS, Demoitie MA, Jin X, Geczy AF, Rowland-Jones SL, McMichael AJ, Nixon DF, Sullivan JS.
Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1.
J Virol. 1999 Jan;73(1):436-43.

Jin X, Roberts CG, Nixon DF, Cao Y, Ho DD, Walker BD, Muldoon M, Korber BT, Koup RA.
Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission.
ARIEL Project Investigators. J Infect Dis. 1998 Nov;178(5):1317-26. Erratum in: J Infect Dis 1999 Jun;179(6):1593.

Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, McMichael AJ.
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
Science. 1998 Mar 27;279(5359):2103-6.

Singh M, Hioe C, Qiu H, Li XM, Wang CY, Koff W, Zamb T, Nixon DF.
CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedure.
Vaccine. 1997 Nov;15(16):1773-8.

Kuebler PJ, Nixon DF.
Cytotoxic T cell induction with ratchet peptide libraries.
Vaccine. 1996 Dec;14(17-18):1664-70.

Nixon DF, Hioe C, Chen PD, Bian Z, Kuebler P, Li ML, Qiu H, Li XM, Singh M, Richardson J, McGee P, Zamb T, Koff W, Wang CY, O'Hagan D.
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.
Vaccine. 1996 Nov;14(16):1523-30.

Hioe CE, Qiu H, Chend PD, Bian Z, Li ML, Li J, Singh M, Kuebler P, McGee P, O'Hagan D, Zamb T, Koff W, Allsopp C, Wang CY, Nixon DF.
Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides.
Vaccine. 1996 Apr;14(5):412-8.

Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N, Kroll JS, Froebel K, McMichael A.
HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant.
Lancet. 1993 Apr 3;341(8849):860-1.

Rowland-Jones SL, Phillips RE, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR, et al.
Human immunodeficiency virus variants that escape cytotoxic T-cell recognition.  
AIDS Res Hum Retroviruses.1992 Aug;8(8):1353-4

Nixon DF, Broliden K, Ogg G, Broliden PA.
Cellular and humoral antigenic epitopes in HIV and SIV.
Immunology. 1992 Aug;76(4):515-34. Review.

Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR, et al.
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.
Nature. 1991 Dec 12;354(6353):453-9.

Nixon DF, McMichael AJ.
Cytotoxic T-cell recognition of HIV proteins and peptides.
AIDS. 1991 Sep;5(9):1049-59.

Nixon DF, Huet S, Rothbard J, Kieny MP, Delchambre M, Thiriart C, Rizza CR, Gotch FM, McMichael AJ.
An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope.
AIDS. 1990 Sep;4(9):841-5.

Huet S, Nixon DF, Rothbard JB, Townsend A, Ellis SA, McMichael AJ.
Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
Int Immunol. 1990;2(4):311-6.

Gotch FM, Nixon DF, Alp N, McMichael AJ, Borysiewicz LK.
High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals.
Int Immunol. 1990;2(8):707-12.

Mills KH, Nixon DF, McMichael AJ.
T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins.
AIDS. 1989;3 Suppl 1:S101-10. Review.

Nixon DF, McMichael AJ.
HIV-gag-specific cytotoxic T lymphocytes.
Res Immunol. 1989 Jan;140(1):107-10; discussion 121. Review.

Nixon DF, Townsend AR, Elvin JG, Rizza CR, Gallwey J, McMichael AJ.
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
Nature. 1988 Dec 1;336(6198):484-7.

Nixon DF, Parsons AJ, Eglin RP.
Routine full blood counts as indicators of acute viral infections.
J Clin Pathol. 1987 Jun;40(6):673-5.

Ting JP, Nixon DF, Weiner LP, Frelinger JA.
Brain Ia antigens have a bone marrow origin.
Immunogenetics. 1983;17(3):295-301.

Waterfield JD, Nixon DF, Mair MG.
Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
Immunology. 1981 Dec;44(4):685-93.

Top